Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.

ABSTRACT:

Background

Due to the preventive nature of disease-modifying therapies for multiple sclerosis, treatment success particularly depends on adherence to therapeutic regimens and patients' perception of treatment efficacy. The latter is strongly influenced by the confidence in the involved health care professionals and the relationship to the treating physician.

Methods

In this report, we considered physicians' and patients' evaluation of satisfaction with interferon beta-1b treatment efficacy for assessing the congruence in ratings. Data were queried in a study conducted between 2009 and 2013.

Results

After 6 months of therapy, > 80 % of the patients and physicians (N = 445) showed high degrees of satisfaction regarding interferon beta-1b treatment, with only few physici

SUBMITTER: Zettl UK 

PROVIDER: S-EPMC5031257 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature